PRMT5 is a critical regulator of breast cancer stem cell function via histone methylation and FOXP1 expression.. by Chiang, K, Zielinska, A, Shaaban, A, Sanchez-Bailon, M, Jarrold, J, Clarke, T, Zhang, J, Francis, A, Jones, L, Smith, S, Barbash, O, Guccione, E, Farnie, G, Smalley, M, Davies, C

Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762 by Chaidos, A, Caputo, V, Gouvedenou, K, Liu, B, Marigo, I, Chaudhry, M, Rotolo, A, Tough, DF, Smithers, NN, Bassil, AK, Chapman, TD, Harker, NR, Barbash, O, Tummino, P, Al-Mahdi, N, Haynes, AC, Cutler, L, Le, B, Rahemtulla, A, Roberts, I, Kleijnen, M, Witherington, J, Parr, NJ, Prinjha, RK, Karadimitris, A